OPKO Health Inc（OPK）财务数据OPKOPKO Health Inc

OPKO Health, Inc. (OPK) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Health Insurers, accounting for 67.1% of total sales, equivalent to $49.99M. Other significant revenue streams include Client Payers and Government Payers. Understanding this composition is critical for investors evaluating how OPK navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, OPKO Health, Inc. maintains a gross margin of 37.32%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -15.31%, while the net margin is -5.14%. These profitability ratios, combined with a Return on Equity (ROE) of -5.88%, provide a clear picture of how effectively OPK converts its operational activities into shareholder value.

In the context of the broader market, OPK competes directly with industry leaders such as LMRI and USPH. With a market capitalization of $1.10B, it holds a significant position in the sector. When comparing efficiency, OPK's gross margin of 37.32% stands against LMRI's 10.90% and USPH's 18.47%. Such benchmarking helps identify whether OPKO Health, Inc. is trading at a premium or discount relative to its financial performance.

In Q2 2026, OPKO reported total revenues of $163.5 million, a 4.3% increase year-over-year, but net income remains negative at -$8.42 million, indicating ongoing financial challenges.